4,893 件 ・ 関連度順
概要と使いどころ
Generate, reference, and conversationally edit short videos with Google's Gemini Omni Flash through the Gemini Developer API or Gemini Enterprise Agent Platform. Use when a task specifically needs Gemini Omni video, multimodal reference roles, time-directed prompting, audio-aware generation, Interactions API state, or a precise comparison with Veo, Nano Banana, consumer Gemini, or gateway routes.
日本語の概要は準備中です。原文の説明を表示しています。
Use Resemble AI Chatterbox for text-to-speech and voice-cloning workflows, including local open-weight Chatterbox, Chatterbox Multilingual, Chatterbox Turbo, and Resemble-hosted Chatterbox API routes. Apply when an agent must choose a Chatterbox variant, prepare reference-voice inputs, control emotion/paralinguistic delivery, plan multilingual TTS, handle PerTh watermarking, or make production decisions about consent, privacy, licensing, latency, and audio QA.
日本語の概要は準備中です。原文の説明を表示しています。
Provider-independent FFmpeg finishing workflow for AI agents preparing generated or edited media deliverables. Use when finalizing images, image sequences, video, audio, captions, overlays, social/export variants, checksums, manifests, delivery specs, and QA with ffmpeg/ffprobe, including transcode versus stream-copy decisions, scaling, frame-rate handling, color metadata caution, loudness normalization, subtitle burn-in or sidecars, concat/trim, GIFs, batch variants, and reproducible command reporting.
日本語の概要は準備中です。原文の説明を表示しています。
Plan, prompt, execute, troubleshoot, and quality-control Black Forest Labs FLUX image generation and editing across the BFL direct API and licensed local/open-weight deployments. Use for FLUX.2 model selection, text-to-image, single- or multi-reference editing, typography, exact-color work, mask-based erase/inpainting, outpainting, API integration, reproducibility, deployment licensing, and production rights or safety decisions; also use when migrating or maintaining legacy FLUX.1/FLUX1.1 workflows.
日本語の概要は準備中です。原文の説明を表示しています。
Provider-independent governance workflow for verifying and correcting human- or model-generated video descriptions. Use for pre-caption critique and post-caption revision, aspect-by-aspect factual review, critique precision/recall/constructiveness, second-stage peer review, calibration, appeals, versioned triplets, provenance, and acceptance reporting; not for pixel/audio QA, accessibility captioning, model training, or creative shot direction.
日本語の概要は準備中です。原文の説明を表示しています。
Produce audio-first podcast episodes with generative tools — design the show and episode format (interview, narrative, news brief, two-host conversational), write scripts for the ear, decide between fully-synthetic and hybrid (recorded human + synthetic) production and meet the disclosure duty each triggers, cast and direct multi-voice TTS for consistency and chemistry, build episode structure (cold open, intro/outro, segments, ad slots), assemble and edit, clear music and SFX rights, hit podcast loudness and delivery standards, ship metadata/chapters/transcripts through RSS, and pass platform AI-content policy and QA before publishing. Use this skill whenever the deliverable is a podcast episode or a podcast show bible, or when an agent must make production, rights, disclosure, or delivery decisions for spoken-word audio. Not for music tracks, single-voice notification prompts, or video where picture leads (route audio-for-video to a video skill).
日本語の概要は準備中です。原文の説明を表示しています。
Provider-independent asset continuity and version management for generated-media production. Use when an agent must track generated or reference assets, prompts, seeds, model/tool versions, manifests, approvals, edit decisions, derivatives, localization variants, metadata/provenance, and continuity QA across image, video, audio, avatar, product-ad, social, explainer, or film-style pipelines.
日本語の概要は準備中です。原文の説明を表示しています。
Provider-independent audio mixing and mastering direction for AI agents finishing generated videos, ads, trailers, explainers, podcasts, recuts, avatar clips, music videos, documentaries, and social content. Use when planning, mixing, repairing, mastering, QCing, or delivering dialogue, music, ambience, and sound effects, including loudness/true-peak targets, intelligibility, accessibility, stems, stereo/immersive decisions, platform/client specs, and final audio QA.
日本語の概要は準備中です。原文の説明を表示しています。
Full enhancement pipeline for an existing Lattice skill — rewrites a molecule or atom to modern-capable-model grade: restores degraded grammar, deduplicates, hardens gates and branching to one-unambiguous-action precision, verifies zero behavioral loss against a pre-capture diff, then runs the combined QA gate (skill-review, skill-tighten, skill-validate) and an independent fresh-context verifier, fixing everything found. Consumer-first: optimized for first-time open-source users on fresh repos with minimal .lattice/ setup, running capable models. Use when the user says 'enhance this skill', 'upgrade this molecule', 'modernize this skill', 'optimize this skill', 'make this skill production grade', 'full enhancement', 'polish this molecule like design-blueprint', or names a molecule/atom to overhaul. For gap-finding only use skill-review; for conventions only use skill-validate — this skill runs the whole loop end to end.
日本語の概要は準備中です。原文の説明を表示しています。
Use when the user wants to design, rewrite, refine, or vary emotional acting prompts for live-action AI video characters. Translate abstract emotions, dialogue, subtext, and scene context into concise, observable, temporally ordered micro-performance directions. Preserve the user's existing character, scene, camera, and dialogue requirements unless they explicitly ask to change them. Do not use for general story writing, shot design, action choreography, or visual asset design when emotional performance is not the main task.
日本語の概要は準備中です。原文の説明を表示しています。
Build forest plots (HR, OR, RR, beta-coefficient summaries with CIs) and funnel plots (meta-analysis publication-bias diagnostics) using forestplot, metafor, ggforest, and MendelianRandomization with proper axis-scaling, summary-diamond placement, subgroup nesting, and Egger / trim-and-fill asymmetry tests. Use when summarizing effects across subgroups, trials, or instruments — meta-analysis, Mendelian randomization, subgroup HRs.
日本語の概要は準備中です。原文の説明を表示しています。
Generates 3D conformer ensembles using RDKit ETKDGv3 with knowledge-enhanced distance geometry, MMFF94/UFF force-field optimization, CREST + GFN2-xTB semi-empirical refinement, and macrocycle-aware torsion preferences. Provides explicit decision rules for single vs ensemble conformer use, RMSD pruning, energy windows, conformer count, and force-field choice. Use when preparing 3D ligands for docking, generating descriptor input for 3D QSAR, or sampling macrocycle/peptide conformational ensembles.
日本語の概要は準備中です。原文の説明を表示しています。
Corrects the gene-independent copy-number artifact in CRISPR-Cas9 screens (Aguirre 2016 / Munoz 2016 Cancer Discov) where amplified loci appear essential from DNA-damage burden of simultaneous cuts. Covers the p53-dependent G2-arrest mechanism, CRISPRcleanR (Iorio 2018) unsupervised pre-hoc correction, CERES (Meyers 2017) joint CN + gene-effect model, Chronos (Dempster 2021) DepMap-standard population-dynamics + CN model with lowest residual bias, the decision tree by data availability, the Spearman LFC-vs-CN diagnostic, focal-amplification examples (ERBB2 in HER2+, MYC in colorectal, FGFR1 in head and neck), and CRISPRi/a alternatives that bypass the artifact. Use when screening cancer cell lines, diagnosing essentiality at amplified loci, choosing CRISPRcleanR / CERES / Chronos, deciding whether CN correction is needed before MAGeCK / BAGEL2 / drugZ, or switching from Cas9 to CRISPRi.
日本語の概要は準備中です。原文の説明を表示しています。
End-to-end post-GWAS causal inference pipeline orchestrating heritability partitioning, genetic correlation, Mendelian randomization with CHP-aware sensitivity (CAUSE / LHC-MR), colocalization, fine-mapping with SuSiE / FOCUS, mediation, TWAS triangulation, cis-pQTL drug-target MR, effector-gene prioritization (L2G / PoPS / cS2G), and GenomicSEM common-factor GWAS. Use when triangulating causal inference across multiple complementary methods, prioritizing tissues via stratified LDSC, nominating or de-risking drug targets, mapping a lead SNP to a candidate effector gene, modeling shared genetic architecture across correlated traits, or producing a STROBE-MR-compliant publication-grade evidence battery from GWAS summary statistics.
日本語の概要は準備中です。原文の説明を表示しています。
Infer cis-regulatory connections (peak-to-peak co-accessibility) from scATAC-seq using Cicero, ArchR getCoAccessibility, or SCENIC+. Use when linking enhancer accessibility to promoter accessibility, identifying enhancer-gene pairs from chromatin alone (without paired RNA), running gene-regulatory inference combining ATAC + RNA, or comparing predicted regulatory contacts against Hi-C/Micro-C ground truth.
日本語の概要は準備中です。原文の説明を表示しています。
Design guides for cytosine and adenine base editing using editing window optimization and BE-Hive outcome prediction. Select optimal positions for C-to-T or A-to-G conversions without double-strand breaks. Use when designing base editor experiments for precise nucleotide changes.
日本語の概要は準備中です。原文の説明を表示しています。
Detects allele-specific transcription factor or histone modification binding from heterozygous-variant ChIP-seq using WASP (reference-bias filter; mandatory upstream), RASQUAL (joint QTL + bias-corrected testing), BaalChIP (Bayesian beta-binomial with copy-number-aware overdispersion), and AlleleSeq (personalized diploid genome). Handles imprinted-locus awareness, X-inactivation artifacts, cancer copy-number imbalance, and integration with downstream caQTL / bQTL mapping. Use when identifying variants with allelic effects on TF binding, fine-mapping causal regulatory variants, validating deep-learning variant predictions, or characterizing cis-acting regulatory effects.
日本語の概要は準備中です。原文の説明を表示しています。
Applies ACMG/AMP 2015 framework with ClinGen SVI specifications, Tavtigian 2018/2020 Bayesian point system, Abou Tayoun 2018 PVS1 decision tree, Pejaver 2022 calibrated PP3/BP4 thresholds for REVEL/BayesDel/AlphaMissense, Brnich 2020 PS3/BS3 OddsPath, Walker 2023 SpliceAI splicing framework, and AMP/ASCO/CAP 2017 tumor tiers. Use when classifying germline variants P / LP / VUS / LB / B, applying VCEP-specific CSpec rules, computing Whiffin BS1, or assigning cancer Tier I-IV per Li 2017.
日本語の概要は準備中です。原文の説明を表示しています。
All-atom protein design using BoltzGen diffusion model. Use this skill when: (1) Need side-chain aware design from the start, (2) Designing around small molecules or ligands, (3) Want all-atom diffusion (not just backbone), (4) Require precise binding geometries, (5) Using YAML-based configuration. For backbone-only generation, use rfdiffusion. For sequence-only design, use proteinmpnn. For structure validation, use boltz.
日本語の概要は準備中です。原文の説明を表示しています。
Prepare for sales conversations with comprehensive account intelligence — company news, hiring signals, product launches, social activity, and decision-maker profiles. Combines firmographic data, news monitoring, and social signals for sales-ready briefings.
日本語の概要は準備中です。原文の説明を表示しています。
Analyze influencer performance metrics across TikTok, Instagram, YouTube, Bilibili, and Kuaishou. Compare engagement rates, audience growth, content consistency, and cross-platform presence for data-driven partnership decisions.
日本語の概要は準備中です。原文の説明を表示しています。
Create or review revenue operations deliverables with traceable assumptions, decision criteria, ownership, and risk controls. Use when the user asks for revenue operations planning or analysis.
日本語の概要は準備中です。原文の説明を表示しています。
Create or review team composition analysis deliverables with traceable assumptions, decision criteria, ownership, and risk controls. Use when the user asks for team composition analysis planning or analysis.
日本語の概要は準備中です。原文の説明を表示しています。
Create or review legal risk assessment deliverables with traceable assumptions, decision criteria, ownership, and risk controls. Use when the user asks for legal risk assessment planning or analysis.
日本語の概要は準備中です。原文の説明を表示しています。